Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA fixes ceiling...

    NPPA fixes ceiling price of Volini Max gel

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-11-11T11:55:31+05:30  |  Updated On 11 Nov 2018 11:55 AM IST
    NPPA fixes ceiling price of Volini Max gel
    New Delhi: Through a recent notice, National Pharmaceutical Pricing Authority (NPPA), has fixed the price of various formulations of Volini Maxx Gel.

    The so fixed retail price is exclusive of goods and services tax. Following table summarises the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;




















































    Sl.
    No.
    Name of the Formulation / Brand Name StrengthUnitManufacturer & Marketing CompanyRetail Price (Rs.)
    (1) (2) (3) (4) (5) (6)
    35.Diclofenac + Methyl

    + Menthol GEL (Volini Maxx Gel)
    Contains:

    Diclofenac Diethylamine BP 2.32% w/w

    (eq. to Diclofenac Sodium 2% w/w),

    Methyl Salcylate IP 10% w/w &

    Menthol IP 5% w/w
    Each Pack (20 gram)M/s Sun Pharmaceutical Industries Ltd.125.00
    36.Diclofenac + Methyl

    + Menthol GEL (Volini Maxx Gel)
    Contains:

    Diclofenac Diethylamine BP 2.32% w/w

    (eq. to Diclofenac Sodium 2% w/w),

    Methyl Salcylate IP 10% w/w &

    Menthol IP 5% w/w
    Each Pack (30 gram)M/s Sun Pharmaceutical Industries Ltd.187.50
    51.Diclofenac + Methyl

    + Menthol GEL (Volini Maxx Gel)
    Contains:

    Diclofenac Diethylamine BP 2.32% w/w

    (eq. to Diclofenac Sodium 2% w/w),

    Methyl Salicylate IP 10% w/w &

    Menthol IP 5% w/w
    Each Pack (15 gram)M/s Sun Pharmaceutical Industries Ltd.93.75
    52.Diclofenac + Methyl

    + Menthol GEL (Volini Maxx Gel)
    Contains:

    Diclofenac Diethylamine BP 2.32% w/w

    (eq. to Diclofenac Sodium 2% w/w),

    Methyl Salcylate IP 10% w/w &

    Menthol IP 5% w/w
    Each Pack (10 gram)M/s Sun Pharmaceutical Industries Ltd.62.50


    Note:
    (a) The manufacturer of above-mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

    (b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.

    (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

    (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

    (e) The above mentioned retail price is applicable only to the individual manufacturer / marketeer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

    (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

    (g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
    ceiling priceDiclofenacDiclofenac Price fixationDPCOEssential Commodities ActIPDMSNational Pharmaceutical Pricing AuthorityNPPAprice fixationretail priceSun Pharmavolini maxx gel

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok